Haplotype diversity in the interleukin-4 gene is not associated with HIV-1 -transmission and aids progression

Immunogenetics

Volumn 55, Issue 3, 2003, Pages 157-164

  Modi, William S ^a   O'Brien, Thomas R ^b   Vlahov, David ^c,h   Buchbinder, Susan ^d   Gomperts, Edward ^e   Phair, John ^f   O'Brien, Stephen J ^g   Winkler, Cheryl ^a  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d S Francisco Dept of Public Health   (United States)

^e CHILDREN S HOSPITAL LOS ANGELES   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

^h NEW YORK ACADEMY OF MEDICINE   (United States)

Author keywords

AIDS; Haplotype diversity; HIV 1; Interleukin 4; Recombination hotspot

Indexed keywords

INTERLEUKIN 4;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BASOPHIL; CYTOKINE PRODUCTION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MAST CELL; POPULATION GENETICS; PRIORITY JOURNAL; REGULATORY MECHANISM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; T LYMPHOCYTE; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; HAPLOTYPES; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-4; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0038683685     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00251-003-0541-5     Document Type: Article

References (44)

1. Ardlie K, Liu-Cordero SN, Eberle MA, Daly M, Barrett J, Winchester E, Lander ES, Kruglyak L (2001) Lower-than-expected linkage disequilibrium between tightly linked markers in humans suggests a role for gene conversion. Am J Hum Genet 69:582-589
2. Borish L, Mascali JJ, Klinnert M, Leppert M, Rosenwasser LJ (1994) SSC polymorphisms in interleukin genes [published erratum appears in Hum Mol Genet (1995) 4:974]. Hum Mol Genet 3:1710
3. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD (1994) Long-term HIV-1 infection without immunologic progression (see comments). AIDS 8:1123-1128
4. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, Kaslow R, Buchbinder S, Hoots K, O'Brien SJ (1999) HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283:1748-1752
5. Centers for Disease Control (1987) Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 36 [Suppl 1]:1-15S
6. Cohen OJ, Kinter A, Fauci AS (1997) Host factors in the pathogenesis of HIV disease. Immunol Rev 159:31-48
7. + T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol 67:1772-1777
8. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, O'Brien SJ (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273:1856-1862
9. Del Prete G, Maggi E, Parronchi P, Chretien I, Tiri A, Macchia D, Ricci M, Banchereau J, De Vries J, Romagnani S (1988) IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 140:4193-4198
10. Detels R, Liu Z, Hennessey K, Kan J, Visscher BR, Taylor JM, Hoover DR, Rinaldo CR Jr, Phair JP, Saah AJ, et al (1994) Resistance to HIV-1 infection. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 7:1263-1269
11. Galli G, Annunziato F, Mavilia C, Romagnani P, Cosmi L, Manetti R, Pupilli C, Maggi E, Romagnani S (1998) Enhanced HIV expression during Th2-oriented responses explained by the opposite regulatory effect of IL-4 and IFN-gamma of fusin/CXCR4. Eur J Immunol 28:3280-3290
12. Gao X, Nelson GW, Karacki P, Martin MP, Phair J, Kaslow R, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, O'Brien SJ, Carrington M (2001) Effect of a single amino acid change in MHC class I molecules on the rate of progression to ADS. N Engl J Med 344:1668-1675
13. Goedert JJ, Kessler CM, Aledort LM, Biggar RJ, Andes WA, White GCD, Drummond JE, Vaidya K, Mann DL, Eyster ME, et al. (1989) A prospective study of human immunodeficiency virus type 1 infection and the development of ADS in subjects with hemophilia (see comments). N Engl J Med 321:1141-1148
14. Hilgartner MW, Donfield SM, Willoughby A, Contant CF Jr, Evatt BL, Gomperts ED, Hoots WK, Jason J, Loveland KA, McKinlay SM, et al (1993) Hemophilia growth and development study. Design, methods, and entry data. Am J Pediatr Hematol Oncol 15:208-218
15. Hudson RR (1990) Gene genealogies and the coelescent press. Oxford surveys in evolutionary biology, vol 1. Oxford
16. Hudson RR, Kaplan NL (1985) Statistical properties of the number of recombination events in the history of a sample of DNA sequences. Genetics 111:147-164
17. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR Jr (1987) The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 126:310-318
18. Klein SA, Dobmeyer JM, Dobmeyer TS, Pape M, Ottmann OG, Helm EB, Hoelzer D, Rossol R (1997) Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 11:1111-1118
19. Long JC, Williams RC, Urbanek M (1995) An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 56:799-810
20. Modi WS, Bergeron J, Sanford M (2001) The human MIP-1beta chemokine is encoded by two paralogous genes, ACT-2 and LAG-1. Immunogenetics 53:543-549
21. Nakayama EE, Hoshino Y, Xin X, Liu H, Goto M, Watanabe N, Taguchi H, Hitani A, Kawana-Tachikawa A, Fukushima M, Yamada K, Sugiura W, Oka SI, Ajisawa A, Sato H, Takebe Y, Nakamura T, Nagai Y, Iwamoto A, Shioda T (2000) Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype. J Virol 74:5452-5459
22. Nakayama EE, Meyer L, Iwamoto A, Persoz A, Nagai Y, Rouzioux C, Delfraissy JF, Debre P, McIlroy D, Theodorou I, Shioda T (2002) Protective effect of interleukin-4 -589T polymorphism on human immunodeficiency virus type 1 disease progression: relationship with virus load. J Infect Dis 185:1183-1186
23. Paul WE (1991) Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 77:1859-1870
24. Przeworski M, Hudson RR, Di Rienzo A (2000) Adjusting the focus on human variation. Trends Genet 16:296-302
25. Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M, Borish L (1995) Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 25 [Suppl 2]:74-78; discussion 95-96
26. Rozas J, Rozas R (2000) DnaSP 3.51. DNA sequence polymorphisms. University of Barcelona, Barcelona
27. Rutherford GW, Lifson AR, Hessol NA, Darrow WW, O'Malley PM, Buchbinder SP, Barnhart JL, Bodecker TW, Cannon L, Doll LS, et al (1990) Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study. BMJ 301:1183-1188
28. Salkowitz JR, Purvis SF, Meyerson H, Zimmerman P, O'Brien TR, Aledort L, Eyster ME, Hilgartner M, Kessler C, Konkle BA, White GC 2nd, Goedert JJ, Lederman MM (2001) Characterization of high-risk HIV-1 seronegative hemophiliacs. Clin Immunol 98:200-211
29. Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Klunk DA, Tomioka K, Newman W, Luscinskas FW, Gimbrone MA Jr, McIntyre BW, et al. (1992) IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 148:1086-1092
30. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, O'Brien SJ (1997) Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 277:959-965
31. Stephens JC, Schneider JA, Tanguay DA, Choi J, Acharya T, Stanley SE, Jiang R, Messer CJ, Chew A, Han JH, Duan J, Carr JL, Lee MS, Koshy B, Kumar AM, Zhang G, Newell WR, Windemuth A, Xu C, Kalbfleisch TS, Shaner SL, Arnold K, Schulz V, Drysdale CM, Nandabalan K, Judson RS, Ruano G, Vovis GF (2001) Haplotype variation and linkage disequilibrium in 313 human genes. Science 293:489-493
32. Swofford DL (1998) PAUP*, Phylogenetic Analysis Using Parsimony (*and other methods). Sunderland, Sinauer, Mass.
33. Tajima F (1989) Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123:585-595
34. Takabayashi A, Ihara K, Sasaki Y, Kusuhara K, Nishima S, Hara T (1999) Novel polymorphism in the 5′-untranslated region of the interleukin-4 gene. J Hum Genet 44:352-353
35. Templeton AR, Clark AG, Weiss KM, Nickerson DA, Boerwinkle E, Sing CF (2000) Recombinational and mutational hotspots within the human lipoprotein lipase gene. Am J Hum Genet 66:69-83
36. Todorova A, Danieli GA (1997) Large majority of single-nucleotide mutations along the dystrophin gene can be explained by more than one mechanism of mutagenesis. Hum Mutat 9: 537-547
37. Tortoni A, Schurr TG, Yang CC, Szathmary EJ, Williams RC, Schanfield MS, Troup GA, Knowler WC, Lawrence DN, Weiss KM, et al (1992) Native American mitochondrial DNA analysis indicates that the Amerind and the Nadene populations were founded by two independent migrations. Genetics 130:153-162
38. Valentin A, Lu W, Rosati M, Schneider R, Albert J, Karlsson A, Pavlakis GN (1998) Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression. Proc Natl Acad Sci USA 95:8886-8891
39. Vitetta ES, Ohara J, Myers CD, Layton JE, Krammer PH, Paul WE (1985) Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1. J Exp Med 162:1726-1731
40. Vlahov D, Polk BF (1988) Perspectives on infection with HIV-1 among intravenous drug users. Psychopharmacol Bull 24:325-329
41. Vlahov D, Graham N, Hoover D, Flynn C, Bartlett JG, Margolick JB, Lyles CM, Nelson KE, Smith D, Holmberg S, Farzadegan H (1998) Prognostic indicators for AIDS and infectious disease death in HIV- infected injection drug users: plasma viral load and CD4+ cell count. JAMA 279:35-40
42. + T lymphocytes and enhance HIV-1 replication. J Leukoc Biol 64:642-649
43. Wasik TJ, Jagodzinski PP, Hyjek EM, Wustner J, Trinchieri G, Lischner HW, Kozbor D (1997) Diminished HIV-specific CTL activity is associated with lower type 1 and enhanced type 2 responses to HIV-specific peptides during perinatal HIV infection. J Immunol 158:6029-6036
44. Winlder C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, Dean M, Honjo T, Tashiro K, Yabe D, Buchbinder S, Vittinghoff E, Goedert JJ, O'Brien TR, Jacobson LP, Detels R, Donfield S, Willoughby A, Gomperts E, Vlahov D, Phair J, O'Brien SJ (1998) Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science 279:389-393